Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice
Weinan Hu,* Wenting Cai,* Yan Wu, Chengda Ren, Donghui Yu, Tingting Li, Tianyi Shen, Ding Xu, Jing Yu Department of Ophthalmology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespon...
Main Authors: | Hu W, Cai W, Wu Y, Ren C, Yu D, Li T, Shen T, Xu D, Yu J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-01-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/topical-application-of-cell-penetrating-peptide-modified-anti-vegf-dru-peer-reviewed-fulltext-article-IJN |
Similar Items
-
Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
by: Yingbin Fu, et al.
Published: (2024-02-01) -
Different approaches for treating myopic choroidal neovascularization: a network Meta-analysis
by: Ya-Jun Wu, et al.
Published: (2023-12-01) -
Effect of vascular endothelial growth factor inhibitors on choroid in patients with macular choroid neovascular membrane and degenerative myopia . Preliminary report
by: V. A. Solomin, et al.
Published: (2014-07-01) -
Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
by: Almila Sarıgül Sezenöz, et al.
Published: (2017-08-01) -
Intravitreal Ranibizumab Therapy for Choroidal Neovascularization Secondary to Pathological Myopia: 3 Year Outcome
by: İrfan Perente, et al.
Published: (2018-04-01)